Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Beta-Blockers Tied to Higher Cataract Risk

But the finding shouldn't affect use of the popular blood pressure drugs, experts say

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Alzheimer's Disease
Cataracts
Central Serous Retinopathy
Conjunctivitis
More...

Related Healthscout Videos
 border=
Shutting Down Tremor.
What's Your Stroke IQ?
Disaster Heart Attacks
Teaching Old Docs New Tricks
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Animation: What is Hypertension?
Erectile Dysfunction
LASIK
More...

Related Drug Information
 border=
Actonel
Coumadin
Detrol LA
Ditropan XL
More...

Related News Articles
 border=
Deadly Stomach Bug Making Inroads Outside Hospitals
Sugar Shortens Life Span in Worms
CDC Finds U.S. 30th in Infant Mortality
Statins May Worsen Fatigue in Heart Failure Patients
More...

THURSDAY, July 23 (HealthDay News) -- Australian researchers are reporting a possible link between widely used beta-blocker drugs and an increased risk of cataracts.

Beta-blockers are used in pill form to reduce high blood pressure and are also applied to the eye to treat glaucoma, a potentially blinding eye disease. The study found an association between both forms of beta-blocker therapy and accelerated cataract formation and a need for cataract surgery, according to the report published July 23 in the British Journal of Ophthalmology by researchers at the Centre for Vision Research at Westmead Hospital in Sydney.

Text Continues Below



The researchers tracked almost 3,700 Australians aged 49 or older for 10 years, looking at a variety of risk factors for cataract, a condition in which clouding of the lens of the eye reduces vision.

The association with beta-blocker use was seen after taking into account such known risk factors as smoking and steroid use.

The study found a 45 percent increased incidence of cataract formation and a 61 percent higher incidence of cataract surgery among people treated with beta-blockers, either for glaucoma or high blood pressure.

A "possible" association between use of a different class of high blood pressure drugs, calcium-channel blockers, and cataract surgery was seen in the study, but no such association was seen for all other drugs for high blood pressure.

The report adds weight to an existing theory of a link between beta-blockers and cataracts, said Dr. Donald L. Budenz, professor of ophthalmology and associate medical director of the University of Miami Bascom Palmer Eye Institute. But it should not affect use of the drugs for either glaucoma or high blood pressure, he said.

Like other forms of glaucoma treatment, topical beta-blocker therapy is designed to reduce the amount of aqueous humor, the fluid in the interior of the eye. Increased fluid pressure in the eye is believed to cause the damage done in glaucoma, in which the optic nerve deteriorates progressively, Budenz said.

Page:  1 | 2 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 7/23/2009

Related Links
 border=
From Healthscout's partner site on high blood pressure, HighBloodPressureConnection.com
Learn more about high blood pressure symptoms.
Have high blood pressure? Learn about blood pressure medications.
Ways to lower blood pressure





SOURCES: Donald L. Budenz, M.D., professor, ophthalmology, associate director, University of Miami Bascom Palmer Eye Institute; Vatinee Bunya, M.D., assistant professor, ophthalmology, University of Pennsylvania Scheie Eye Institute, Philadelphia; July 2009 British Journal of Ophthalmology


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy